RFU Startup Preparing For Pivotal Clinical Trial On Novel Therapy For Sudden Cardiac Arrest
Resuscitation Therapeutics (RTx) — an RFU early-stage company focused on developing new therapies…
News Archive, Page 7: Filtered to Research
Multidrug Resistance Study Awarded $1.3 Million Federal Grant
Structural biologist Min Lu, PhD, was recently awarded a four-year, $1.3 million grant from the National Institutes…
Two RFU Researchers Among Illinois Science and Technology Coalition's Fifth Annual "Researchers to Know"
Biomedical researchers Joanna Dabrowska, PhD, PharmD, and Noah Rosenblatt, PhD, were recently recognized…
Pair of Federal Grants Fund Studies on Diabetic Foot Ulcers and Prevention of Falls
Separate grants totaling $1.2 million from the National Institutes of Health and the Department…
RFU Scientist Awarded $2.36 Million to Study Potential Therapeutic targets for Anxiety Disorders
RFU researcher Joanna Dabrowska, PhD, PharmD, has been awarded a $2.36 million grant by the National…
Industry and Academic Experts Line Up for New Bioinnovations Speaker Series
RFU announces the launch of its new BioInnovations Speaker series, which debuted on Oct. 19 in-person…
Treating 9/11 First Responders: Can Genetics Predict Severity of PTSD?
Last September, people across the United States and the world commemorated the 20th anniversary of the 9/11 attacks…
Patent Portfolios Bridge the Gap Between Innovation and the Public Good
Entrepreneur in Residence Peter Paredes, JD, advises Helix 51 incubator companies and other startups, universities and…
Invisible and Stigmatized: What Unique Health Disparities Affect Bisexual Individuals?
Nationally representative surveys reveal that 3% of adults and 6% of adolescents in the United States…
‘Perhaps the Greatest Challenge’: How To Get Capital Behind Concepts
Michael Beaubaire, MD, who was named the first Entrepreneur in Residence for Helix 51, is the principal of Beaubaire…